SRS Implant - Anchorless Single-Incision System

Please note, that this product is currently only available in certain markets. Please contact us to find out details about your country.
Benefits
Improves Quality of Life
Levy et al. showed a significant improvement in quality of life in the long-term follow-up of the SRS-I and SRS-II trial.1
Simple and fast
The preparation of the paravaginal space is similar to that of other transvaginal meshes. For the experienced surgeon the operation is therefore easy to perform. The mean operative time in the SRS-II trial was 24.7 minutes.1
Proven safety
No intraoperative complications occurred in the SRS-I and SRS-II trial. No mesh erosion or chronic pain was documented during the entire follow-up.1
Anatomically excellent reconstruction
After a median follow-up of 38.4 months, 60/70 patients (85.7%) had a POP-Q stage 0 and 6/70 patients (8.6%) had a POP-Q stage 1.1
[1] Levy et al., Surgical treatment of advanced anterior wall and apical vaginal prolapse using the anchorless self-retaining support implant: long-term follow-up, Int Urogynecol J. 2022, 13: 1-9
Technical Data
Knowledge
Application Range
The SRS Implant is intended for the treatment of anterior vaginal wall prolapse with/without apex/uterine prolapseVaginocele is the protrusion of the vagina to the outside caused by weakening of the pelvic floor muscles. Prolapse of the vagina without protrusion through the vaginal orifice is known as first-degree uterine prolapse…. The SRS Implant is indicated for use in adult females (> 21 years) suffering from anterior vaginal wall prolapse POP-Q ≥ stage 2 (point Ba > -1 cm).
Manufacturer
- Lyra Medical Ltd., HaMelacha 3, Binyamina, Israel 3057324
Ordering Information
Article number | Delivery unit (VPE) |
---|---|
6001399 | 1 pcs |
Downloads
Additional information
Please note:
Not all products are available in every country.
Please refer to the respective country websites:
For all other countries please use the contact form to enquire about availability for your country.